NASDAQ: BPMC - Blueprint Medicines Corporation

Rentabilidade por seis meses: +8.21%
Rendimento de dividendos: 0.00%
Setor: Healthcare

Cronograma de promoção Blueprint Medicines Corporation

Agenda avançada Gráfico simples
Financial Markets by TradingView

Sobre a empresa Blueprint Medicines Corporation

Blueprint Medicines Corporation разрабатывает препараты низкомолекулярных ингибиторов киназы, которые нацелены на геномные факторы при геномно определенных раках, редких заболеваниях и иммунотерапии рака. Компания разрабатывает авапритиниб для лечения системного мастоцитоза (СМ) и опухолей стромы желудочно-кишечного тракта; BLU-263, орально доступный мощный ингибитор KIT для лечения вялотекущего SM и других заболеваний тучных клеток; и физогатиниб, орально доступный и мощный ингибитор, который находится в фазе I клинических испытаний для лечения запущенной гепатоцеллюлярной карциномы.

mais detalhes
Он также разрабатывает пралсетиниб, доступный для перорального применения и мощный ингибитор, нацеленный на RET, рецепторную тирозинкиназу для лечения немелкоклеточного рака легкого с измененным RET, медуллярной карциномы щитовидной железы и других солидных опухолей. Кроме того, компания разрабатывает BLU-782, пероральный и исследуемый ингибитор активин-подобной киназы 2, который проходит фазу I клинических испытаний для лечения прогрессирующей оссифицирующей фибродисплазии. У него есть соглашения о сотрудничестве и лицензионные соглашения с Clementia Pharmaceuticals, Inc .; CStone Pharmaceuticals; Genentech, Inc .; и F. Hoffmann-La Roche Ltd и Hoffmann-La Roche Inc. Компания ранее была известна как Hoyle Pharmaceuticals, Inc. и сменила название на Blueprint Medicines Corporation в июне 2011 года. Blueprint Medicines Corporation была основана в 2008 году, ее штаб-квартира находится в Кембридже. , Массачусетс.
Adicionar à lista de comparação
Adicionar à lista de observação
Adicionar ao portfólio
Adicionar aviso de preço

IPO date 2015-04-30
ISIN US09627Y1091
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт https://www.blueprintmedicines.com
Цена ао 103.56
Alteração de preço por dia: 0% (103.56)
Alteração de preço por semana: -5.53% (109.62)
Alteração de preço por mês: +0.975% (102.56)
Alteração de preço em 3 meses: +8.27% (95.65)
Mudança de preço em seis meses: +8.21% (95.7)
Mudança de preço por ano: +18.26% (87.57)
Mudança de preço em 3 anos: +72.77% (59.94)
Mudança de preço em 5 anos: +73.5% (59.69)
Mudança de preço em 10 anos: 0% (103.56)
Mudança de preço desde o início do ano: +15.84% (89.4)
Todos os parâmetros

Subestimação

Nome Significado Nota
P/S 21.57 1
P/BV 41.19 1
P/E 15.98 7
EV/EBITDA -12.82 0
Total: 4

Eficiência

Nome Significado Nota
ROA, % -48.32 0
ROE, % -388.17 0
Total: 0

Dividendos

Nome Significado Nota
Div yield, % 0 0
DSI 0 0
Total: 0

Obrigação

Nome Significado Nota
Debt/EBITDA -0.6109 10
Total: 8

Impulso de crescimento

Nome Significado Nota
Rentabilidade Revenue, % 275.01 10
Rentabilidade Ebitda, % 30.18 5
Rentabilidade EPS, % 21.86 4
Total: 6.6
Mais detalhes

Data da transação Data de divulgação Insider Tipo Preço Volume Quantidade Compartilhe até, % Compartilhe depois, % Documento
13.01.2025 15.01.2025 Hurley Ariel
PRINCIPAL ACCOUNTING OFFICER		 Oferta 100 225 000 2250 0 0 link
13.01.2025 15.01.2025 Hurley Ariel
PRINCIPAL ACCOUNTING OFFICER		 Comprar 36.05 81 113 2250 0 0 link
13.01.2025 15.01.2025 Albers Jeffrey W.
Director		 Oferta 102.28 511 400 5000 0 -0.01 link
13.01.2025 15.01.2025 Albers Jeffrey W.
Director		 Comprar 36.05 180 250 5000 0 0.01 link
27.11.2024 02.12.2024 Rossi Christina
CHIEF OPERATING OFFICER		 Oferta 95.1 216 257 2274 0 0 link
27.11.2024 27.11.2024 Christina Rossi and Gregory Pa
Affiliate		 Comprar 94.63 860 754 9096 0 0.02 link
09.09.2024 11.09.2024 Albers Jeffrey W.
Director		 Oferta 85.57 1 685 900 19702 0 -0.03 link
09.09.2024 11.09.2024 Albers Jeffrey W.
Director		 Comprar 36.05 360 500 10000 0 0.02 link
09.09.2024 09.09.2024 Albers Jeffrey W.
Director		 Comprar 85.57 1 685 900 19702 0 0.03 link
15.08.2024 15.08.2024 MICHAEL LANDSITTEL
Officer		 Comprar 95.23 419 869 4409 0 0.01 link
05.07.2024 08.07.2024 Durso-Bumpus Debra
CHIEF PEOPLE OFFICER		 Oferta 111.2 428 120 3850 0 -0.01 link
05.07.2024 08.07.2024 Durso-Bumpus Debra
CHIEF PEOPLE OFFICER		 Comprar 54.13 208 401 3850 0 0.01 link
03.07.2024 08.07.2024 Durso-Bumpus Debra
CHIEF PEOPLE OFFICER		 Oferta 111.29 981 244 8817 0 -0.01 link
03.07.2024 08.07.2024 Durso-Bumpus Debra
CHIEF PEOPLE OFFICER		 Comprar 54.13 477 264 8817 0 0.01 link
28.06.2024 02.07.2024 Durso-Bumpus Debra
CHIEF PEOPLE OFFICER		 Oferta 111.15 37 013 333 0 0 link
28.06.2024 02.07.2024 Durso-Bumpus Debra
CHIEF PEOPLE OFFICER		 Comprar 54.13 18 025 333 0 0 link
21.06.2024 25.06.2024 Durso-Bumpus Debra
CHIEF PEOPLE OFFICER		 Oferta 104.19 7 713 600 74034 0 -0.13 link
21.06.2024 25.06.2024 Durso-Bumpus Debra
CHIEF PEOPLE OFFICER		 Comprar 34.48 2 085 420 60482 0 0.1 link
05.06.2024 07.06.2024 Carter Percy H.
CHIEF SCIENTIFIC OFFICER		 Oferta 105.13 420 520 4000 0 -0.01 link
04.06.2024 06.06.2024 Hewes L. Becker
CHIEF MEDICAL OFFICER		 Oferta 104.91 254 302 2424 0 0 link
03.06.2024 04.06.2024 Hewes L. Becker
CHIEF MEDICAL OFFICER		 Oferta 106.43 523 848 4922 0 -0.01 link
31.05.2024 04.06.2024 Hewes L. Becker
CHIEF MEDICAL OFFICER		 Oferta 105.91 3 612 380 34108 0 -0.06 link
31.05.2024 04.06.2024 Hewes L. Becker
CHIEF MEDICAL OFFICER		 Comprar 59.21 1 461 720 24687 0 0.04 link
08.05.2024 10.05.2024 Landsittel Michael
CHIEF FINANCIAL OFFICER		 Comprar 2.32 65 380 28181 0 0.05 link
07.03.2024 26.03.2024 Albers Jeffrey W.
Director		 Oferta 90.69 1 000 580 11033 0 -0.02 link
28.02.2024 01.03.2024 Murray Christopher K.
CHIEF TECHNICAL OPERATIONS		 Oferta 100 500 000 5000 0 -0.01 link
28.02.2024 01.03.2024 Murray Christopher K.
CHIEF TECHNICAL OPERATIONS		 Comprar 54.13 270 650 5000 0 0.01 link
25.01.2024 29.01.2024 Albers Jeffrey W.
Director		 Oferta 81.91 2 047 750 25000 0 -0.04 link
25.01.2024 29.01.2024 Albers Jeffrey W.
Director		 Comprar 7.13 178 250 25000 0 0.04 link
11.12.2023 13.12.2023 Albers Jeffrey W.
Director		 Oferta 79.07 395 350 5000 0 -0.01 link
11.12.2023 13.12.2023 Albers Jeffrey W.
Director		 Comprar 36.05 180 250 5000 0 0.01 link
04.12.2023 06.12.2023 Murray Christopher K.
CHIEF TECHNICAL OPERATIONS		 Oferta 71.43 42 858 600 0 0 link
30.11.2023 04.12.2023 Albers Jeffrey W.
Director		 Oferta 70.55 352 750 5000 0 -0.01 link
30.11.2023 04.12.2023 Albers Jeffrey W.
Director		 Comprar 36.05 180 250 5000 0 0.01 link
05.06.2023 07.06.2023 Hewes L. Becker
CHIEF MEDICAL OFFICER		 Oferta 52.05 73 078 1404 0 0 link
05.06.2023 07.06.2023 Carter Percy H.
CHIEF SCIENTIFIC OFFICER		 Oferta 52.06 120 102 2307 0 0 link
24.08.2022 26.08.2022 Durso-Bumpus Debra
CHIEF PEOPLE OFFICER		 Oferta 75.11 375 550 5000 0 -0.01 link
24.08.2022 26.08.2022 Durso-Bumpus Debra
CHIEF PEOPLE OFFICER		 Comprar 15.01 75 050 5000 0 0.01 link
16.08.2022 18.08.2022 Albers Jeffrey W.
Director		 Oferta 68.41 1 368 200 20000 0 -0.03 link
16.08.2022 18.08.2022 Albers Jeffrey W.
Director		 Comprar 8.44 168 800 20000 0 0.03 link
08.08.2022 10.08.2022 Albers Jeffrey W.
Director		 Oferta 70.07 700 700 10000 0 -0.02 link
08.08.2022 10.08.2022 Albers Jeffrey W.
Director		 Comprar 6.84 68 400 10000 0 0.02 link

Instituições Volume Compartilhar, %
Blackrock Inc. 6584176 10.76
Vanguard Group Inc 6114970 9.99
Price (T.Rowe) Associates Inc 5428955 8.87
FMR, LLC 4348311 7.11
Wellington Management Group, LLP 4276333 6.99
Rock Springs Capital Management, LP 2881567 4.71
State Street Corporation 2424200 3.96
Pictet Asset Management Holding SA 1753547 2.87
William Blair Investment Management, LLC 1727845 2.82
T. Rowe Price Investment Management, Inc. 1598789 2.61

ETF Compartilhar, % Rentabilidade para o ano, % Dividendos, %
Tema Oncology ETF 3.30318 30.23 0.55
Invesco Biotechnology & Genome ETF 2.69322 26.49 0.16298
WisdomTree BioRevolution Fund 2.20675 -4.69 0.78691
Range Cancer Therapeutics ETF 1.39253 47.24 0.11955
Virtus LifeSci Biotech Products ETF 1.2386 36.79 0.13953
American Century Focused Dynamic Growth ETF 1.20606 51.92 0.16246
Invesco Dorsey Wright Healthcare Momentum ETF 1.19242 6.18 0.12263
Direxion Daily S&P Biotech Bull 3x Shares 0.7148 4067.92 0.25924
Future Tech ETF 0.56343 426.34 0.8416
Principal Healthcare Innovators ETF 0.56343 618.5 0.8416
Invesco Nasdaq Biotechnology ETF 0.54895 28.58 0.8565
ProShares UltraShort Nasdaq Biotechnology 0.48 -40.36 1.76
First Trust Mid Cap Growth AlphaDEX Fund 0.46089 26.95 0.9035
Goldman Sachs Future Health Care Equity ETF 0.4598 16.15 0.84646
First Trust Nasdaq Pharmaceuticals ETF 0.4573 18.37 2.19901
Vanguard Russell 2000 Growth ETF 0.45 23.05 0.60264
Global X Aging Population ETF 0.44963 20.37 1.46713
John Hancock Multifactor Small Cap ETF 0.43676 16.88 1.54912
iShares Russell 2000 Growth ETF 0.42613 38.04 0.6026
ProShares Ultra Nasdaq Biotechnology 0.37177 51.7 0.85651
First Trust Active Factor Small Cap ETF 0.35405 34.25 1.61948
Invesco Dorsey Wright SmallCap Momentum ETF 0.29937 33.91 0.61241
Vanguard U.S. Momentum Factor ETF 0.26 30.05 1.05834
iShares Morningstar Small-Cap Growth ETF 0.24378 33.63 0.72598
iShares Morningstar Small-Cap Growth ETF 0.24378 587.89 0.72598
First Trust Mid Cap Core AlphaDEX Fund 0.23136 18.49 1.65423
Vanguard Russell 2000 ETF 0.22 17.16 1.48801
BNY Mellon US Mid Cap Core Equity ETF 0.17241 30.41 1.5641
Fidelity Small-Mid Multifactor ETF 0.16997 32.31 1.59943
JPMorgan BetaBuilders U.S. Mid Cap Equity ETF 0.14877 21.79 1.42082
Schwab U.S. Small-Cap ETF 0.14458 17.47 1.51433
First Trust Multi Cap Growth AlphaDEX Fund 0.13883 41.56 1.02425
SoFi Next 500 ETF 0.1312 29.56 1.43041
ProShares UltraPro Russell2000 0.12449 89.82 1.47873
iShares Morningstar Small-Cap ETF 0.12208 30.1 1.60498
iShares Morningstar Small-Cap ETF 0.12208 391.25 1.60498
iShares U.S. Tech Breakthrough Multisector ETF 0.10427 21.8 0.73986
First Trust Active Factor Mid Cap ETF 0.09905 39.15 1.88793
Goldman Sachs ActiveBeta US Small Cap Equity ETF 0.09118 31.36 1.41955
Vanguard Extended Market ETF 0.08 24.2 1.34786
Fidelity MSCI Health Care Index ETF 0.07756 3 1.46057
iShares ESG Aware MSCI USA Small-Cap ETF 0.07706 18.09 1.49366
QRAFT AI Enhanced U.S. Large Cap ETF 0.06031 31.16 1.25914
ProShares Hedge Replication ETF 0.03441 5.92 1.47892
John Hancock Multifactor Mid Cap ETF 0.03247 20.65 1.52586
Humankind US Stock ETF 0.03205 18.81 1.99919
Invesco FTSE RAFI US 1500 Small-Mid ETF 0.02991 17.58 1.75869
Vanguard ESG U.S. Stock ETF 0.02 23.54 1.26927
FlexShares Morningstar US Market Factor Tilt Index Fund 0.01626 21.94 1.69572
iShares Dow Jones U.S. ETF 0.01094 25.05 1.41797
Goldman Sachs MarketBeta U.S. 1000 Equity ETF 0.01072 33 1.42661
iShares Russell 3000 ETF 0.01049 24.83 1.43482
Schwab U.S. Broad Market ETF 0.01011 24.86 1.43354
Vanguard Russell 3000 ETF 0.01 31.87 1.43817
Avantis U.S. Equity ETF 0.00617 23.04 1.59151
Avantis Responsible U.S. Equity ETF 0.00049 26.78 1.45257



Supervisor Cargo Pagamento Ano de nascimento
Mr. Michael Landsittel Chief Financial Officer 785.36k 1972 (53 ano)
Dr. Percy H. Carter M.B.A., Ph.D. Chief Scientific Officer 761.15k 1970 (55 anos)
Mr. Alexis A. Borisy A.M. Co-Founder & Director 50k 1972 (53 ano)
Ms. Tracey L. McCain Esq. Executive VP, Chief Legal & Compliance Officer and Secretary 764.9k 1968 (57 anos)
Dr. Fouad Namouni M.D. President of Research & Development 916.4k 1969 (56 anos)
Jenna Cohen Senior Director & Head of Investor Relations N/A
Dr. Christopher K. Murray Ph.D. Chief Technical Operations & Quality Officer 338.37k 1963 (62 ano)
Ms. Ariel Hurley Senior VP, Finance & Principal Accounting Officer N/A 1974 (51 ano)
Ms. Kathryn Haviland M.B.A. President, CEO & Director 1976 (49 anos)
Ms. Christina Rossi M.B.A. Chief Operating Officer 1976 (49 anos)

Endereço: United States, Cambridge, MA -, 45 Sidney Street - abrir no Google Maps, abrir mapas Yandex
Site: https://www.blueprintmedicines.com